IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE

Generic: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE

Sun Pharmaceutical IndustriesManufacturer
RESPIRATORY (INHALATION)Route
IPRATROPIUM BROMIDEActive Substance
2017-08-07Original Approval

IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE is FDA application ANDA207875, sponsored by SUN PHARM. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2020-09-16
Albuterol Sulfate Inhalation Aerosol, 90 mcg per actuation, 200 metered inhalations, Manufactured by: Catalent Pharma So

Defective Delivery System: Sustained trend of failure to dispense complaints.

Class II2022-04-13
Albuterol Sulfate Inhalation Solution 0.083%, 2.5 mg/3mL, packaged in 5 x 3 mL unit-dose vials, Rx only, Manufactured by

cGMP deviations: Temperature abuse

Class III2025-07-24
Albuterol Sulfate, Inhalation Aerosol, 90 mcg, 200 metered Inhalations, NET CONTENT 6.7 g, Manufactured by: Cipla Ltd, I

Failed Stability Specifications: Out of specification results was observed in Induction Port during

Class II2013-10-02
Albuterol Sulfate Inhalation Solution, 0.083% 2.5 mg/3 mL for Oral Inhalation Only, Rx Only, 25 x 3 mL Sterile Unit-Dos

Lack of Assurance of Sterility: Nephron Pharmaceuticals Corporation conducted a routine periodic ase

Class II2022-04-13
Albuterol Sulfate Inhalation Aerosol HFA 90 mcg, with Dose Indicator, 200 metered inhalations, Rx only, Distributed by:

cGMP deviations: Temperature abuse

Class II2024-03-26
Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton

Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in t

Class I2023-06-27
Albuterol Sulfate Inhalation Aerosol, 90 mcg, 200 Metered Inhalation, net content 6.7 g canister packaged in a box, Rx o

Defective container: empty inhaler and leakage observed through the inhaler valve due to partially m

Class II2015-08-21
Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution, packaged in 30x3 mL Sterile Unit-Dose Vials,

Lack of Assurance of Sterility; potential exposure to non-sterile lubricant during the filling proce

Class II2011-06-22
Albuterol Sulfate Inhalation Solution, 0.083%, 2.5 mg/3 mL Sterile Unit-Dose Vials, 60-count (60 x 3 mL Sterile Unit-Dos

Lack of Assurance of Sterility

Class II2022-01-26
Ipratropium Bromide and Albuterol Sulfate Inhalation Solution (0.5 mg/3 mg per 3 mL), 60 x 3 mL Sterile Unit-Dose Vials

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage condi

Top Reported Reactions

1
DYSPNOEA
29,753 reports
2
ASTHMA
15,712 reports
3
DRUG INEFFECTIVE
14,695 reports
4
COUGH
14,103 reports
5
FATIGUE
12,090 reports
6
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS
11,882 reports
7
HEADACHE
11,342 reports
8
DEVICE DELIVERY SYSTEM ISSUE
11,280 reports
9
NAUSEA
11,171 reports
10
PNEUMONIA
11,148 reports